Weight & Metabolic Health · Dual GIP/GLP-1 agonist

Tirzepatide

10 mg · lyophilized vialWeekly subcutaneous injectionEstablished

A dual-agonist alternative your provider may consider based on your history, response and tolerability — never on request.

01Considered where GLP-1 response or tolerability falls short
02Same monthly review and titration discipline as GLP-1 Care
03Protein and strength targets run alongside the medication
04Switching agents is a provider decision with a plan attached
Prescription only. This vial is dispensed within a programme after a provider reviews your intake — it is not sold on its own, and enrolling does not guarantee it will be prescribed.
SOHOMDTirzepatide10 mg · lyophilized vialRX ONLY · ILLUSTRATIVEIllustration — not actual packaging
In programme
$—/ month, if prescribed
Shown in full before you pay. Figures unconfirmed.
Check availabilityWeight & Metabolic Health programmes
Provider evaluation and review cadence
Dose management by your provider
Licensed-pharmacy dispensing and tracking
Messaging with your care team

Important medical information

Read before enrolling
Not right for everyone

Contraindications, warnings and precautions to be reproduced from approved labeling before publication. Tell your provider about your full medical history and every medication you take.

Side effects

Common and serious adverse effects to be listed from approved sources. Contact your care team if symptoms are severe or persistent — treatment is paused or adjusted when it should be.

Emergencies

This programme is not for urgent or emergency care. In a medical emergency, call 911 or go to the nearest emergency department.

A provider decides — start there.

Pick your state and we'll tell you straight away whether the relevant programme is available.

This formulary is illustrative. Names, strengths, forms and pricing are placeholders pending clinical, pharmacy and legal sign-off. Nothing here is sold on its own: medication is dispensed by a licensed pharmacy inside a programme, only after a provider decides it belongs in your plan — and no is a real answer.